2018
DOI: 10.1093/abbs/gmy149
|View full text |Cite
|
Sign up to set email alerts
|

Progression of carotid artery disease could stratify a risk of coronary artery disease patients with type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 12 publications
0
7
0
Order By: Relevance
“…Patients with type-2 diabetes have an elevated proinflammatory profile, which drives the progression of atherosclerosis (i.e., endothelial dysfunction), leading to arterial media/intima thickening and plaque formation [5,7]. The progression of CAD in patients with diabetes accelerates, as a cohort study reported that after a 2.5 year follow-up, patients developed new plaques, angina, and carotid intima/media thickness [6], despite 80% of the patients taking medications. As such, treating hyperglycemia is crucial before the disease accelerates CVD development.…”
Section: Beneficial Effects Of Taurine In Diabetes and Obesitymentioning
confidence: 99%
See 2 more Smart Citations
“…Patients with type-2 diabetes have an elevated proinflammatory profile, which drives the progression of atherosclerosis (i.e., endothelial dysfunction), leading to arterial media/intima thickening and plaque formation [5,7]. The progression of CAD in patients with diabetes accelerates, as a cohort study reported that after a 2.5 year follow-up, patients developed new plaques, angina, and carotid intima/media thickness [6], despite 80% of the patients taking medications. As such, treating hyperglycemia is crucial before the disease accelerates CVD development.…”
Section: Beneficial Effects Of Taurine In Diabetes and Obesitymentioning
confidence: 99%
“…Subject Dose/Time Outcome [205,207] Heart Failure 1500 mg/day, 2 weeks Improved exercise capacity, reduced TC/HDL-c, and reduced hsCRP [208] Chronic Heart Failure 3000 mg/day, 30-45 days Decreased left ventricular end-diastolic volume with left ventricular dysfunction before revascularization [209] Chronic Heart Failure 3000 mg/day, 6 CBS, cystathionine β synthase deficiency; FBS, fasting blood sugar; HDL-c, high-density lipid cholesterol; hsCRP, high-sensitivity C-reactive protein; LDL-c, low-density lipid cholesterol; TC, total cholesterol.…”
Section: Refmentioning
confidence: 99%
See 1 more Smart Citation
“…3 Cerebrovascular disease is an independent risk factor for prognosis of patients with coronary artery disease. 4 In this study, 1 patients with prior stroke/TIA had significantly increased 1-year reinfarction as well as in-hospital and 1-year bleeding. On the other hand, the authors 1 refer to no benefits or harms observed with different antithrombotic therapies or dual antipletelet therapy in these patients.…”
mentioning
confidence: 53%
“…3 Cerebrovascular disease is an independent risk factor for prognosis of patients with coronary artery disease. 4…”
mentioning
confidence: 99%